Boston Scientific Corporation: Cardiovascular Diseases trials
The registry lists 11 Cardiovascular Diseases studies with Boston Scientific Corporation as lead sponsor. 0 are open to participants now and 3 have results posted.
Phase 1 1Phase 4 1No phase 9(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Evaluate the Performance and Safety of Comet Pressure Guidewire in the Measurement of FFRCompletedNCT04098172Not applicableResults posted
- Multicenter Automatic Defibrillator Implantation Trial With Subcutaneous Implantable Cardioverter DefibrillatorCompletedNCT02787785Not applicableResults posted
- SYNERGY China: Assess SYNERGY Stent in ChinaCompletedNCT02499692Not applicableResults posted
- Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial FibrillationActive, not recruitingNCT06096337Not applicable
- A U.S Post Approval Study Evaluating the SYNERGY XLV (MEGATRON) Stent SystemCompletedNCT04807439
- A Feasibility Study of the Millipede Transcatheter Annuloplasty Ring System in Patients With Functional Mitral RegurgitationActive, not recruitingNCT04147884Not applicable
- A Clinical Trial to Confirm Safety & Effectiveness of the SYNERGY 4.50 mm and 5.00 mm Stent for Treatment of Atherosclerotic Lesion(s)CompletedNCT03875651
- A Post-Approval, Single-Arm Study of the SYNERGY Stent System in ChinaActive, not recruitingNCT03736226
- Precision Event Monitoring for Patients With Heart Failure Using HeartLogicCompletedNCT03579641
- TAXUS ARRIVE 2: A Multi-Center Safety Surveillance ProgramCompletedNCT00569751Phase 4
- Safety Study to Assess the Feasibility of Use in Humans of the TAXUS Petal Bifurcation Coronary Stent SystemCompletedNCT00497367Phase 1